255 related articles for article (PubMed ID: 25855779)
21. Abnormalities of the PRMT1-ADMA-DDAH1 metabolism axis and probucol treatment in diabetic patients and diabetic rats.
Mei X; Zeng J; Liu DF; Zhao Y; Yang HL; Li Y; Qiu P; Tang MW
Ann Palliat Med; 2021 Mar; 10(3):3343-3353. PubMed ID: 33849119
[TBL] [Abstract][Full Text] [Related]
22. Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas.
Boult JK; Walker-Samuel S; Jamin Y; Leiper JM; Whitley GS; Robinson SP
J Pathol; 2011 Nov; 225(3):344-52. PubMed ID: 21590769
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia.
Rodionov RN; Dayoub H; Lynch CM; Wilson KM; Stevens JW; Murry DJ; Kimoto M; Arning E; Bottiglieri T; Cooke JP; Baumbach GL; Faraci FM; Lentz SR
Circ Res; 2010 Feb; 106(3):551-8. PubMed ID: 20019334
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling.
Kopaliani I; Jarzebska N; Billoff S; Kolouschek A; Martens-Lobenhoffer J; Bornstein SR; Bode-Böger SM; Ragavan VN; Weiss N; Mangoni AA; Deussen A; Rodionov RN
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H825-H838. PubMed ID: 34533401
[TBL] [Abstract][Full Text] [Related]
25. Asymmetric Dimethylarginine Enables Depolarizing Spikes and Vasospasm in Mesenteric and Coronary Resistance Arteries.
Ng YYH; Dora KA; Lemmey HAL; Lin J; Alden J; Wallis L; Donovan L; Shorthose O; Leiper FC; Leiper J; Garland CJ
Hypertension; 2024 Apr; 81(4):764-775. PubMed ID: 38226470
[TBL] [Abstract][Full Text] [Related]
26. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.
Lange C; Mowat F; Sayed H; Mehad M; Duluc L; Piper S; Luhmann U; Nandi M; Kelly P; Smith A; Ali R; Leiper J; Bainbridge J
Exp Eye Res; 2016 Jun; 147():148-155. PubMed ID: 27181226
[TBL] [Abstract][Full Text] [Related]
27. Repetitive ischemia increases myocardial dimethylarginine dimethylaminohydrolase 1 expression.
Zhang P; Fassett JT; Zhu G; Li J; Hu X; Xu X; Chen Y; Bache RJ
Vasc Med; 2017 Jun; 22(3):179-188. PubMed ID: 28145161
[TBL] [Abstract][Full Text] [Related]
28. DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts.
Zhao C; Li T; Han B; Yue W; Shi L; Wang H; Guo Y; Lu Z
Free Radic Biol Med; 2016 Mar; 92():50-60. PubMed ID: 26806551
[TBL] [Abstract][Full Text] [Related]
29. Dimethylarginine dimethylaminohydrolase1 is an organ-specific mediator of end organ damage in a murine model of hypertension.
Sydow K; Schmitz C; von Leitner EC; von Leitner R; Klinke A; Atzler D; Krebs C; Wieboldt H; Ehmke H; Schwedhelm E; Meinertz T; Blankenberg S; Böger RH; Magnus T; Baldus S; Wenzel U
PLoS One; 2012; 7(10):e48150. PubMed ID: 23110194
[TBL] [Abstract][Full Text] [Related]
30. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
Wetzel MD; Gao T; Stanley K; Cooper TK; Morris SM; Awad AS
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F509-F517. PubMed ID: 31904280
[TBL] [Abstract][Full Text] [Related]
31. Extensive characterization of the human DDAH1 transgenic mice.
Schwedhelm E; von Leitner EC; Atzler D; Schmitz C; Jacobi J; Meinertz T; Münzel T; Baldus S; Cooke JP; Böger RH; Maas R; Sydow K
Pharmacol Res; 2009 Dec; 60(6):494-502. PubMed ID: 19666120
[TBL] [Abstract][Full Text] [Related]
32. Effects of dimethylarginine dimethylaminohydrolase-1 overexpression on the response of the pulmonary vasculature to hypoxia.
Bakr A; Pak O; Taye A; Hamada F; Hemeida R; Janssen W; Gierhardt M; Ghofrani HA; Seeger W; Grimminger F; Schermuly RT; Witzenrath M; Brandes RP; Huang N; Cooke JP; Weissmann N; Sommer N
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):491-500. PubMed ID: 23642043
[TBL] [Abstract][Full Text] [Related]
33. Dimethylarginine Dimethylaminohydrolase 1 Protects Against High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice.
Li T; Feng R; Zhao C; Wang Y; Wang J; Liu S; Cao J; Wang H; Wang T; Guo Y; Lu Z
Antioxid Redox Signal; 2017 Apr; 26(11):598-609. PubMed ID: 27565538
[TBL] [Abstract][Full Text] [Related]
34. Asymmetric dimethylarginine, endothelial dysfunction and renal disease.
Aldámiz-Echevarría L; Andrade F
Int J Mol Sci; 2012; 13(9):11288-11311. PubMed ID: 23109853
[TBL] [Abstract][Full Text] [Related]
35. Endothelial Dimethylarginine Dimethylaminohydrolase 1 Is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic Homeostasis.
Dowsett L; Piper S; Slaviero A; Dufton N; Wang Z; Boruc O; Delahaye M; Colman L; Kalk E; Tomlinson J; Birdsey G; Randi AM; Leiper J
Circulation; 2015 Jun; 131(25):2217-25. PubMed ID: 25910799
[TBL] [Abstract][Full Text] [Related]
36. Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease.
Liu X; Xu X; Shang R; Chen Y
Nitric Oxide; 2018 Aug; 78():113-120. PubMed ID: 29928990
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine.
Hu X; Xu X; Zhu G; Atzler D; Kimoto M; Chen J; Schwedhelm E; Lüneburg N; Böger RH; Zhang P; Chen Y
Circulation; 2009 Dec; 120(22):2222-9. PubMed ID: 19917889
[TBL] [Abstract][Full Text] [Related]
38. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
Lind L; Ingelsson E; Kumar J; Syvänen AC; Axelsson T; Teerlink T
Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
[TBL] [Abstract][Full Text] [Related]
39. Dimethylarginine dimethylaminohydrolase 1 regulates nerve growth factor-promoted differentiation of PC12 cells in a nitric oxide-dependent but asymmetric dimethylargenine-independent manner.
Wang S; Hu CP; Yuan Q; Zhang WF; Zhou Z; Nie SD; Jiang JL; Li YJ
J Neurosci Res; 2012 Jun; 90(6):1209-17. PubMed ID: 22488726
[TBL] [Abstract][Full Text] [Related]
40. ADMA elevation does not exacerbate development of diabetic nephropathy in mice with streptozotocin-induced diabetes mellitus.
Rodionov RN; Jarzebska N; Schneider A; Rexin A; Sradnick J; Brilloff S; Martens-Lobenhoffer J; Bode-Böger SM; Todorov V; Hugo C; Weiss N; Hohenstein B
Atheroscler Suppl; 2019 Dec; 40():100-105. PubMed ID: 31818438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
